How do you like your Christmas lights? We all have our preferences, and we’re spoiled for choice, making it easy to decorate our trees exactly the way we want. You can pick white lights, multi-color ...

A dog trainer has shared her simple yet effective method for getting curious and excited pups to stay away from Christmas trees this December. Taking to TikTok,. a dog trainer under the username ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Saddle systems improve every year. What once seemed like a niche piece of gear that lived in the periphery of more mainstream whitetail hunting alternatives, saddle hunting is the beneficiary of the ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

We may receive a commission on purchases made from links. Here at SlashGear, we're no strangers to loving a good garage hack, like using wall-mounted storage, mason jars, and labels. That said, we're ...